| September 3, Beijing Sinovac Biotech Co., Ltd. | | | | Manager Fan Bei sighed, To Influenza H1N1 influenza |
| Production of influenza A H1N1 Influenza Vaccine | | | | vaccine, nearly all regard the corporate masters of |
| States Food And Drug Administration issued a drug | | | | the staff, daily work around the clock, skip meals is |
| approval number, which is world's first production | | | | common. |
| batch of influenza A H1N1 was the flu vaccine. June 8 | | | | 9 1st, Hualan material developed influenza A H1N1 |
| from the enterprise received from the World Health | | | | influenza split vaccine formal review by the Centre |
| Organization can be directly used for vaccine | | | | National Drug expert review, and is expected to be in |
| production strains counting, the vaccine development | | | | the September 4 issued by the State Food and Drug |
| cycle in just 87 days short. | | | | Administration drug approval number. This from the |
| Development, trial production, clinical trials, on-site | | | | company to get the standard strains, only 3 months, |
| inspection, registration inspection, review and approval | | | | with Beijing Sinovac almost simultaneously. |
| ... ... to be completed in the shortest time H1N1 flu | | | | "Population is compared with other countries facing a |
| influenza vaccine development, vaccine | | | | major challenge, the vaccine can be put into use as |
| manufacturers in China, drug testing oversight body, | | | | early as one day, one day, and susceptible |
| disease control and other departments Contact | | | | populations of key groups, we can minimize the |
| Cooperation Battle against time, so that the people in | | | | damage caused by an influenza pandemic." Beijing |
| order to achieve the goal of vaccination as early as | | | | Branch Xing Wei-Dong Yin, Managing Director of |
| one day, go all out. | | | | Biological Products, said. |
| "Development of a vaccine as early as one day, one | | | | In business while stepping up research and |
| day people will be able to be protected" | | | | development, government departments has also |
| 2009 4 months, influenza A H1N1 influenza virus | | | | been active. June to August, the State Food and |
| spread from North America to the world, influenza | | | | Drug Administration have issued "on the good |
| prevention and control of a sudden started this | | | | Influenza H1N1 influenza vaccine production |
| campaign. Prevention and control of influenza as the | | | | preparation work to inform," "special approval of |
| most effective means of communication, H1N1 | | | | pandemic influenza vaccine program of emergency," a |
| vaccine development and production were high | | | | series of documents, review and approval for the |
| hopes. Can developed a vaccine as early as one day, | | | | vaccine work laid the basis of a policy. |
| it means that people can one day be protected. | | | | In the "does not reduce the standard does not |
| Access to the World Health Organizationstrains is the | | | | reduce the" principle, the State Food and Drug |
| basis for enterprises to develop vaccines. At 20 | | | | Administration requested the review of Influenza |
| o'clock on the June 3, in customs, quality inspection | | | | H1N1 influenza vaccine approved part of the "three |
| departments with the cooperation of the | | | | simultaneous", ie drugs to the technical review and |
| WHO-accredited laboratories in the influenza A H1N1 | | | | evaluation center sub-synchronous enterprise |
| influenza strain used for vaccine production in Henan | | | | reporting, drug Certification Center will produce |
| arriving at headquarters in stock limited Hualan | | | | on-site inspection and the production process of |
| Biological Engineering company. As China's first obtain | | | | synchronization of Pharmaceutical and Biological |
| strains for vaccine production enterprise, Hualan | | | | Products for use in clinical samples and the batch |
| things started in the first influenza H1N1 influenza | | | | release testing and simultaneous self businesses. |
| vaccine. | | | | "It is the deployment of science to achieve optimum |
| "Whether it is scientific research, management, or | | | | workflow and maximize efficiency for influenza H1N1 |
| front-line workers, from this moment on, all against | | | | influenza vaccine development and production for a |
| the clock." Looking back over the past three months, | | | | time." State Food and Drug Administration drug |
| Hualan Biological Engineering Co., Ltd. Deputy General | | | | registration Secretary Zhang Wei said. |